Anpario plc (LON:ANP – Get Free Report) insider Marc Wilson purchased 3,778 shares of the stock in a transaction that occurred on Tuesday, April 1st. The stock was bought at an average cost of GBX 398 ($5.21) per share, with a total value of £15,036.44 ($19,701.83).
Anpario Stock Down 7.0 %
ANP opened at GBX 351.50 ($4.61) on Friday. Anpario plc has a twelve month low of GBX 229.50 ($3.01) and a twelve month high of GBX 488.55 ($6.40). The company’s 50-day moving average price is GBX 428.63 and its two-hundred day moving average price is GBX 377.29. The stock has a market cap of £59.97 million, a price-to-earnings ratio of 19.41 and a beta of 0.58. The company has a quick ratio of 5.16, a current ratio of 6.15 and a debt-to-equity ratio of 0.10.
Anpario (LON:ANP – Get Free Report) last announced its quarterly earnings data on Monday, March 31st. The company reported GBX 28.40 ($0.37) earnings per share for the quarter. Anpario had a return on equity of 8.74% and a net margin of 9.23%. As a group, equities analysts expect that Anpario plc will post 23.5757801 earnings per share for the current year.
Anpario Increases Dividend
Analysts Set New Price Targets
Several research analysts recently weighed in on ANP shares. Shore Capital restated a “house stock” rating on shares of Anpario in a report on Monday. Canaccord Genuity Group boosted their target price on Anpario from GBX 380 ($4.98) to GBX 500 ($6.55) and gave the stock a “buy” rating in a research note on Tuesday, January 14th.
Get Our Latest Research Report on Anpario
About Anpario
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
Further Reading
- Five stocks we like better than Anpario
- How to Invest in Insurance Companies: A Guide
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- What is the MACD Indicator and How to Use it in Your Trading
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- How to Short a Stock in 5 Easy Steps
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.